Trial intelligence / Profile preview

Urine CXCL10 Monitoring in Renal Transplant

NCT03140514Completed

Sponsor
University Hospital Basel
Start
Sep 2017
Primary completion
Jul 2022
Countries
1
01

Overview

Randomised, single-blind trial (2 arms), sponsored by University Hospital Basel. Primary endpoints: Graft loss not due to death of the patient at 1 year, Biopsy-proven clinical acute rejection at 1 year and 2 more. Started Sep 2017; status: completed.

Beyond the preview

Go deeper on NCT03140514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03140514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call